Crystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US8067639B2 · kind B2 · utility
1Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2008 |
| Grant date | Nov 29, 2011 |
| Priority date | — |
| Expiry date | Jul 24, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Crystalline form VI of the compound of formula (I):characterised by its X-ray powder diffraction diagram.Medicinal products containing the same which are useful in treating melatoninergic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.